Transplanted organoids empower human preclinical assessment of drug candidate for the clinic.

Autor: Westerling-Bui AD; Goldfinch Bio Inc., Cambridge, MA 02142, USA., Fast EM; Goldfinch Bio Inc., Cambridge, MA 02142, USA., Soare TW; Goldfinch Bio Inc., Cambridge, MA 02142, USA., Venkatachalan S; Goldfinch Bio Inc., Cambridge, MA 02142, USA., DeRan M; Diamond Age Data Science, Somerville, MA 02143, USA., Fanelli AB; Goldfinch Bio Inc., Cambridge, MA 02142, USA., Kyrychenko S; Goldfinch Bio Inc., Cambridge, MA 02142, USA., Hoang H; Goldfinch Bio Inc., Cambridge, MA 02142, USA., Corriea GM; Goldfinch Bio Inc., Cambridge, MA 02142, USA., Zhang W; Goldfinch Bio Inc., Cambridge, MA 02142, USA., Yu M; Goldfinch Bio Inc., Cambridge, MA 02142, USA., Daniels M; Goldfinch Bio Inc., Cambridge, MA 02142, USA., Malojcic G; Goldfinch Bio Inc., Cambridge, MA 02142, USA., Pan-Zhou XR; Goldfinch Bio Inc., Cambridge, MA 02142, USA., Ledeboer MW; Goldfinch Bio Inc., Cambridge, MA 02142, USA., Harmange JC; Goldfinch Bio Inc., Cambridge, MA 02142, USA., Emani M; Broad Institute of MIT and Harvard, Cambridge, MA 02142, USA., Tibbitts TT; Goldfinch Bio Inc., Cambridge, MA 02142, USA., Reilly JF; Goldfinch Bio Inc., Cambridge, MA 02142, USA., Mundel P; Goldfinch Bio Inc., Cambridge, MA 02142, USA.

Publikováno v: Science advances [Sci Adv] 2022 Jul 08; Vol. 8 (27), pp. eabj5633. Date of Electronic Publication: 2022 Jul 06.